iifl-logo

Syngene International Ltd Historical Data

638.9
(-0.58%)
Jun 30, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Syngene International Ltd Historical Data

30/05/2025calendar-icon
30/06/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

02-Jun-2025

642.05

651.4564264920,84037,34,90,604.753,55,432

03-Jun-2025

650.25

654.4638.5641.0513,80822,94,07,452.551,68,025

04-Jun-2025

641.05

648.65639.9647.410,54415,24,97,116.551,32,117

05-Jun-2025

651

651.95645.85646.78,82314,29,11,035.751,20,483

06-Jun-2025

646.7

649.55641.95646.0510,62216,85,62,749.951,35,042

09-Jun-2025

646.05

659646.05656.4515,15452,49,81,534.754,91,402

10-Jun-2025

660

667655658.229,03068,94,68,223.554,82,528

11-Jun-2025

659.9

667.6657.3662.5519,65859,28,38,352.45,45,513

12-Jun-2025

667.6

671659.6663.1524,1951,11,06,96,483.4511,82,075

13-Jun-2025

655

662.2651653.123,45945,86,59,996.053,36,212

16-Jun-2025

661

662.8651660.3523,67542,72,11,126.72,17,843

17-Jun-2025

662

663.4647649.1517,09355,03,87,641.955,12,518

18-Jun-2025

648

651.55641644.5513,13331,19,33,034.72,39,345

19-Jun-2025

645.05

648625.1627.2526,08225,79,66,599.72,14,210

20-Jun-2025

625

636624.35631.221,46773,59,48,528.48,69,453

23-Jun-2025

632

638.7627.45636.0526,00728,97,89,774.352,11,798

24-Jun-2025

639

644.95637.2638.8522,42062,46,70,333.57,34,889

25-Jun-2025

638

652.95638651.442,55771,46,09,086.66,03,804

26-Jun-2025

650

653.8641.5645.734,08098,67,06,722.911,83,888

27-Jun-2025

649.6

653.4640.5642.6546,98897,76,55,50310,54,260

30-Jun-2025

646.4

649.45635.05638.922,09826,55,87,790.052,27,580

Syngene Intl.: Related NEWS

Syngene Gets FDA Nod on Biocon Park Inspection With VAI Status
15 Jun 2025|09:00 PM

The outcome of the inspection has been classified as “Voluntary Action Indicated” or VAI.

Read More
Syngene Reports ₹1,018 Crore Revenue in Q4 FY25
24 Apr 2025|01:21 PM

The purchase is anticipated to enhance Syngene's position in the biologics contract development and manufacturing organization (CDMO) arena, specifically in the US market.

Read More
Syngene International reports better than expected Q4 results
24 Apr 2025|11:36 AM

The company reported an operating EBITDA of ₹343.60 Crore in the quarter four of FY25. It registered a growth of 8.4% on a year-on-year basis.

Read More
Syngene Boosts Biologics Capacity with US Facility Acquisition
13 Mar 2025|01:40 PM

This acquisition will also augment Syngene’s biologics capabilities and further strengthen its global presence.

Read More
Syngene Reports 18% Profit Surge in Q3, Revenue Up 10.6%
24 Jan 2025|12:45 PM

The company's revenue from operations also grew healthily, up by 10.6% YoY to ₹943 crore, as against ₹853.5 crore in Q3 FY24.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.